Return Home

about IAS-USA
news and events
cme
course registration
Cases on the Web
publications/guidelines
guidelines
Oral Manifestations Resource Card
Dermatologic Manifestations of HIV
Drug Resistance Mutations
Webcast and Podcasts
Frequently Asked Questions
board and staff
Disclosure Information
Policy on Faculty Disclosures and Conflicts of Interest
core faculty
donations
contact
home


IAS–USA Board of Directors Disclosure Information

The non-staff members of the IAS–USA Board of Directors participate in a volunteer capacity. They are not compensated for their role in governing/overseeing the IAS–USA.

In accordance with IAS–USA policy on disclosure and conflicts of interest, information regarding conflicts of interest is obtained from all parties with control over activity content (ie, directors, officers, activity chairs, faculty, authors, and IAS–USA staff), and conflicts of interest of those parties are resolved.

Below are the financial interests that the volunteer members of the Board of Directors have had with commercial companies within the last 12 months of the date of disclosure (noted next to each):

Dr Benson received research grants awarded to University of California, San Diego from Gilead Sciences. Dr Benson served on advisory boards for Boehringer Ingelheim, GlaxoSmithKline, Merck, and Pfizer, and chaired Data and Safety Monitoring Boards for Johnson & Johnson Research, Ltd. (Australia) and Achillion. (Updated 2/15/08)

Dr Currier (3/12/07-2/15/08) received research grants to UCLA from Tibotec, Merck, GlaxoSmithKline and Theratechnologies and served as a consultant or received honoraria from Bristol-Myers Squibb, Pfizer, Merck, and Tibotec. In addition she serves on a data safety monitoring board for Koronnis and Achillion Pharmaceuticals. (Updated 02/15/08)

Dr del Rio (3/12/07–2/15/08) received research grants to Emory University from Merck, GlaxoSmithKline, Pfizer, the CDC and the NIH. He served as a consultant or received honoraria from Merck, Trinity Biotech and BMS. (Updated 02/15/08)

Dr Gallant received research grants awarded to Johns Hopkins University School of Medicine from Gilead, GlaxoSmithKline, Merck, Pfizer, Roche, and Tibotec, and honoraria from Abbott, Gilead, GlaxoSmithKline, Monogram Biosciences, and Tibotec. He served as a scientific advisor or consultant to Abbott, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck, Panacos, Pfizer, RAPID Pharmaceuticals, Schering Plough, Tibotec, and Vertex. He is a member of Data Safety and Monitoring Boards for Abbott, Gilead, and Koronis. (Updated 02/15/08)

Dr Gulick received research grants to Cornell University from Panacos, Pfizer, Schering, and Tibotec. He served as an ad-hoc scientific advisor or consultant to Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck, Monogram Biosciences, Pfizer, Schering, Trimeris, Virco, and Virostatics. He also serves as Chair of a DSMB for Koronis. (Updated 03/19/08)

Ms Jacobsen had no relevant financial affiliations to disclose. (Updated 03/22/07)

Dr Richman served as a consultant to Anadys, Biota, Bristol-Myers Squibb, Boehringer Ingelheim, Gilead, Idinex, Koronis, Merck, Monogram, Pfizer, Roche, and Tobira. (Updated 02/19/08)

Dr Saag received grants and research support from, and has been a scientific advisor to Boehringer Ingelheim, Gilead, GlaxoSmithKline, Merck, Monogram Biosciences, Panacos, Pfizer, Progenics, Roche, Tibotec, and Virco. (Updated 02/18/08)

Dr Schooley served as a consultant to Achillion, Gilead, GlaxoSmithKline, Koronis, Merck, Monogram, Pfizer, TaiMed, Tibotec, and Vertex. He had stock options for Archillion and Monogram. (Updated 01/15/08)

Dr Volberding, during the period from 1/1/07 through 1/1/08, served on scientific advisory boards for Bristol-Myers Squibb, Gilead, Pfizer, and Schering, and was on the endpoint adjudication committee of Schering for an ongoing clinical trial. He received an unrestricted educational grant from GSK-Italy. (Updated 02/15/08)







© Copyright 2008. International AIDS Society-USA. All rights reserved.
Use of this site is subject to the Visitor's Agreement and Privacy and Confidentiality Policy.
Policy on Disclosure and Conflicts of Interest.
Please read them carefully.

Return to Top